Pasithea Therapeutics (KTTA) Shares Outstanding (Diluted Average) (2021 - 2024)
Historic Shares Outstanding (Diluted Average) for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $1.0 million.
- Pasithea Therapeutics' Shares Outstanding (Diluted Average) fell 1900.84% to $1.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.0 million, marking a year-over-year decrease of 1900.84%. This contributed to the annual value of $1.2 million for FY2023, which is 283.12% down from last year.
- Latest data reveals that Pasithea Therapeutics reported Shares Outstanding (Diluted Average) of $1.0 million as of Q3 2024, which was down 1900.84% from $1.0 million recorded in Q2 2024.
- Over the past 5 years, Pasithea Therapeutics' Shares Outstanding (Diluted Average) peaked at $26.5 million during Q3 2022, and registered a low of $1.0 million during Q1 2024.
- Its 4-year average for Shares Outstanding (Diluted Average) is $7.9 million, with a median of $1.3 million in 2023.
- Per our database at Business Quant, Pasithea Therapeutics' Shares Outstanding (Diluted Average) soared by 19642.81% in 2022 and then plummeted by 9514.4% in 2023.
- Over the past 4 years, Pasithea Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $10.4 million in 2021, then plummeted by 87.87% to $1.3 million in 2022, then fell by 2.83% to $1.2 million in 2023, then dropped by 14.87% to $1.0 million in 2024.
- Its Shares Outstanding (Diluted Average) was $1.0 million in Q3 2024, compared to $1.0 million in Q2 2024 and $1.0 million in Q1 2024.